Home/Pipeline/NeuCA15‑3 Test

NeuCA15‑3 Test

Breast Cancer Monitoring

Phase 1Active

Key Facts

Indication
Breast Cancer Monitoring
Phase
Phase 1
Status
Active
Company

About INOVIQ

Australian cancer‑diagnostics and exosome‑therapeutics company with commercial assays and a growing pipeline.

View full company profile

Therapeutic Areas